Literature DB >> 17083540

Optical coherence tomography versus automated perimetry for follow-up of optic neuritis.

Susana Noval1, Inés Contreras, Gema Rebolleda, Francisco J Muñoz-Negrete.   

Abstract

PURPOSE: To evaluate the usefulness of optical coherence tomography (OCT) for follow-up of optic neuritis (ON) compared with subjective visual function tests.
METHODS: Twelve patients with ON underwent a complete ophthalmological evaluation at initial diagnosis, including best corrected visual acuity (VA), visual fields testing and OCT examination. These examinations were repeated periodically over 6 months. Retinal nerve fibre layer (RNFL) thickness evolution was analysed and correlated with VA and visual field mean deviation.
RESULTS: Six months after ON, mean RNFL in the affected eye decreased significantly compared with that in the fellow eye (24.54%). A significant correlation was found between RNFL thinning and final VA (r = 0.807, p = 0.005), with a 1-line drop in VA for every 5.4-micro m decrease. All patients with an altered visual field had an abnormal RNFL value; of the seven patients with normal visual fields, 57% had an abnormal RNFL value (p < 5%).
CONCLUSIONS: Optical coherence tomography can detect axonal damage as early as the third month after an isolated initial episode of ON, even in the presence of normal visual fields. Mean RNFL thinning is correlated with final VA.

Entities:  

Mesh:

Year:  2006        PMID: 17083540     DOI: 10.1111/j.1600-0420.2006.00724.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  22 in total

1.  Comparison of retinal nerve fiber layer measured by time domain and spectral domain optical coherence tomography in optic neuritis.

Authors:  G Rebolleda; A García-García; H R Won Kim; F J Muñoz-Negrete
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis.

Authors:  Aldina Reis; Catarina Mateus; M Carmo Macário; José R Faria de Abreu; Miguel Castelo-Branco
Journal:  J Neurol       Date:  2011-03-31       Impact factor: 4.849

3.  Relationship between Structural and Functional Assessment of the Visual System in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients.

Authors:  Nergiz Huseyinoglu; Metin Ekinci; Serkan Ozben; Cagatay Buyukuysal
Journal:  Neuroophthalmology       Date:  2014-01-28

Review 4.  OCT: New perspectives in neuro-ophthalmology.

Authors:  Gema Rebolleda; Laura Diez-Alvarez; Alfonso Casado; Carmen Sánchez-Sánchez; Elisabet de Dompablo; Julio J González-López; Francisco J Muñoz-Negrete
Journal:  Saudi J Ophthalmol       Date:  2014-10-05

5.  Retinal ganglion cell and axonal loss in optic neuritis: risk factors and visual functions.

Authors:  T H Lee; Y S Ji; S W Park; H Heo
Journal:  Eye (Lond)       Date:  2016-11-18       Impact factor: 3.775

6.  Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.

Authors:  Michal Laron; Han Cheng; Bin Zhang; Jade S Schiffman; Rosa A Tang; Laura J Frishman
Journal:  Mult Scler       Date:  2009-12-07       Impact factor: 6.312

7.  Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.

Authors:  Michal Laron; Han Cheng; Bin Zhang; Jade S Schiffman; Rosa A Tang; Laura J Frishman
Journal:  Mult Scler       Date:  2010-03-05       Impact factor: 6.312

8.  Optic Atrophy in End-Stage Giant Axonal Neuropathy: A Case Report.

Authors:  T J Wubben; A O Eghrari; A N McCoy; D J Ramsey
Journal:  Neuroophthalmology       Date:  2013-09-24

Review 9.  Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis.

Authors:  C Lamirel; N J Newman; V Biousse
Journal:  Rev Neurol (Paris)       Date:  2010-06-01       Impact factor: 2.607

10.  Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship.

Authors:  Alexander Klistorner; H Arvind; T Nguyen; R Garrick; M Paine; S Graham; J O'Day; C Yiannikas
Journal:  Doc Ophthalmol       Date:  2008-09-09       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.